Prognostic value of MGMT gene promoter methylation status in glioblastoma: A prospective study of patients treated with radiotherapy and temozolomide

Background: Glioblastoma (GBM) is the most aggressive primary brain tumor. O6-methylguanine-deoxyribonucleic acid-methyltransferase (MGMT) mediates resistance to temozolomide (TMZ). Epigenetic silencing of the MGMT gene promoter by hypermethylation has been proposed as a prognostic and predictive bi...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Tushar Marbate, Sourabh Zambre, Reshama Kailuke, Rohini Chaudhari, Mayur Ingle
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Manipal College of Medical Sciences, Pokhara 2026-07-01
Colecção:	Asian Journal of Medical Sciences
Assuntos:	glioblastoma; o6-methylguanine-deoxyribonucleic acid-methyltransferase promoter methylation; temozolomide; stupp protocol; methylation-specific polymerase chain reaction; prognostic biomarker; overall survival; neuro-oncology
Acesso em linha:	https://ajmsjournal.info/index.php/AJMS/article/view/5401
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!